Fentanyl System Patch
Product Images NDC 47781-427

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Fentanyl System (NDC 47781-427). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alvogen, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Fen04 0006 01)

Chemical structure of fentanyl, the active ingredient in the Fentanyl system transdermal patch. The diagram shows its molecular configuration with labeled chemical groups and rings.*

FDA Label Image

Figure (Fen04 0006 02)

An instructional diagram of a Fentanyl transdermal patch showing its three layers: release liner, drug containing layer, and backing layer. The diagram visually explains the patch structure for the Fentanyl system by ALVOGEN.*

FDA Label Image

Figure 1 (Fen04 0006 03)

A line graph showing fentanyl concentration (ng/mL) over time (hours) comparing single (1x) versus quadruple (4x) dosing of Fentanyl Transdermal System 100 mcg/h. The graph includes error bars and depicts concentration changes over approximately 340 hours.*

FDA Label Image

Parts Of The Fentanyl Transdermal System Patch (Fen04 0006 04)

An illustration showing the components of a transdermal fentanyl patch. It labels the protective liner, the drug-containing layer, and the backing layer of the patch in a partially peeled-back view.*

FDA Label Image

Figure A (Fen04 0006 05)

An anatomical illustration showing the upper torso of a person with a Fentanyl system transdermal patch applied to the upper left chest area, demonstrating proper placement of the patch on the skin.*

FDA Label Image

Figure B (Fen04 0006 06)

Illustration showing a transdermal fentanyl patch applied to the upper back of a person, demonstrating correct placement for the Fentanyl system patch by Alvogen, used for delivering fentanyl through the skin.*

FDA Label Image

Figure C (Fen04 0006 07)

An anatomical illustration shows a shirtless male torso from the side with a transdermal patch applied to the lower back. The patch represents the application site for a fentanyl transdermal system patch, demonstrating proper placement on the skin for drug delivery.*

FDA Label Image

Figure D (Fen04 0006 08)

An illustration showing the proper placement of a Fentanyl transdermal patch on the upper arm of a person. The patch is a small, square adhesive applied to the skin.*

FDA Label Image

Figure E (Fen04 0006 09)

FDA Label Image

Figure F (Fen04 0006 10)

An instructional image showing a person's hands peeling the backing off a Fentanyl system patch prior to application. The patch is small and rectangular, consistent with a transdermal medication delivery system.*

FDA Label Image

Figure G (Fen04 0006 11)

An instructional diagram showing hands handling a fentanyl transdermal patch. The image likely demonstrates how to properly remove the patch's backing before application.*

FDA Label Image

Figure H (Fen04 0006 12)

FDA Label Image

Figure I (Fen04 0006 13)

An instructional illustration showing two hands pulling on opposite sides of a fentanyl transdermal patch to separate it from its protective liner before application.*

FDA Label Image

Figure J (Fen04 0006 14)

An instructional black-and-white illustration demonstrating the proper use of the Fentanyl transdermal patch. The image shows a hand pressing the patch onto the skin, highlighting application technique.*

FDA Label Image

Principal Display Panel (12 mcg/h Patch Carton)

Fentanyl system 12 mcg/h transdermal patch packaging label by Alvogen. The label shows the product name and strength, warnings about serious breathing problems, usage instructions, and storage details. It includes a red section indicating it is for opioid-tolerant patients only and contains five patches per package. The label also provides contact information for Alvogen and indicates narcotic usage recording space.*

FDA Label Image

Principal Display Panel (25 mcg/h Patch Carton)

Packaging label for Fentanyl Transdermal System patch, 25 mcg/h strength, manufactured by Alvogen. The label includes warnings, inactive ingredients, dosage information, and packaging details for five patches. It specifies opioid-tolerant patients only and provides contact information for Alvogen. The label features a yellow background with red accents and a pink triangle indicating strength.*

FDA Label Image

Principal Display Panel (50 mcg/h Patch Carton)

Packaging label for Fentanyl Transdermal System 50 mcg/h patch by Alvogen. The label is primarily yellow with green and red accents, stating it is for opioid-tolerant patients only. It includes directions on storage, warnings about breathing problems, and instructions to keep out of children's reach. The package contains five transdermal systems delivering 50 mcg/h fentanyl, with the labeler and manufacturer information noted.*

FDA Label Image

Principal Display Panel (75 mcg/h Patch Carton)

Packaging label for Fentanyl Transdermal System patch, 75 mcg/h strength, distributed by Alvogen. The label shows instructions for use, warnings about serious breathing problems, storage conditions, and contact information for the manufacturer Kindeva Drug Delivery L.P. The package contains five patches. The label emphasizes use by opioid-tolerant patients only.*

FDA Label Image

Principal Display Panel (100 mcg/h Patch Carton)

Packaging label for Fentanyl Transdermal System patch, 100 mcg/h strength. The label shows a yellow background with black and red text, emphasizing use only for opioid-tolerant patients. It includes instructions on storage and usage, warnings about serious breathing problems, and distribution details by Alvogen, Inc. The label specifies a package size of five patches.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.